Literature DB >> 24619879

CXCL1/CXCL8 (GROα/IL-8) in human diabetic ketoacidosis plasma facilitates leukocyte recruitment to cerebrovascular endothelium in vitro.

Tatsushi Omatsu1, Gediminas Cepinskas, Cheril Clarson, Eric K Patterson, Ibrahim M Alharfi, Kelly Summers, Pierre-Olivier Couraud, Ignacio A Romero, Babette Weksler, Douglas D Fraser.   

Abstract

Diabetic ketoacidosis (DKA) in children is associated with intracranial vascular complications, possibly due to leukocyte-endothelial interactions. Our aim was to determine whether DKA-induced inflammation promoted leukocyte adhesion to activated human cerebrovascular endothelium. Plasma was obtained from children with type 1 diabetes either in acute DKA or in an insulin-controlled state (CON). Plasma concentrations of 21 inflammatory analytes were compared between groups. DKA was associated with altered circulating levels of ↑CXCL1 (GROα), ↑CXCL8 (IL-8), ↑IL-6, ↑IFNα2, and ↓CXCL10 (IP-10) compared with CON. These plasma analyte measurements were then used to create physiologically relevant cytokine mixtures (CM). Human cerebral microvascular endothelial cells (hCMEC/D3) were stimulated with either plasma (DKA-P or CON-P) or CM (DKA-CM or CON-CM) and assessed for polymorphonuclear leukocyte (PMN) adhesion. Stimulation of hCMEC/D3 with DKA-P or DKA-CM increased PMN adhesion to hCMEC/D3 under "flow" conditions. PMN adhesion to hCMEC/D3 was suppressed with neutralizing antibodies to CXCL1/CXCL8 or their hCMEC/D3 receptors CXCR1/CXCR2. DKA-P, but not DKA-CM, initiated oxidative stress in hCMEC/D3. Expression of ICAM-1, VCAM-1, and E-selectin were unaltered on hCMEC/D3 by either DKA-P or DKA-CM. In summary, DKA elicits inflammation in children associated with changes in circulating cytokines/chemokines. Increased CXCL1/CXCL8 instigated PMN adhesion to hCMEC/D3, possibly contributing to DKA-associated intracranial vascular complications.

Entities:  

Keywords:  CXC chemokine ligand; brain; cell trafficking; chemokines; diabetes; growth-regulated oncogene-α; human; inflammation; ketoacidosis; neutrophils; pediatric

Mesh:

Substances:

Year:  2014        PMID: 24619879     DOI: 10.1152/ajpendo.00659.2013

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  21 in total

Review 1.  The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.

Authors:  Antonio Citro; Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

2.  Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis.

Authors:  William H Hoffman; Cornelia D Cudrici; Dallas Boodhoo; Alexandru Tatomir; Violeta Rus; Horea Rus
Journal:  Exp Mol Pathol       Date:  2019-04-13       Impact factor: 3.362

3.  Biomarkers and genetics of brain injury risk in diabetic ketoacidosis: A pilot study.

Authors:  Sholeen T Nett; Janelle A Noble; Daniel L Levin; Natalie Z Cvijanovich; Monica S Vavilala; J Dean Jarvis; Heidi R Flori
Journal:  J Pediatr Intensive Care       Date:  2014

4.  Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case-control analyses.

Authors:  João Pedro Ferreira; Anne Pizard; Jean-Loup Machu; Emmanuel Bresso; Hans-Peter Brunner-La Rocca; Nicolas Girerd; Céline Leroy; Arantxa González; Javier Diez; Stephane Heymans; Marie-Dominique Devignes; Patrick Rossignol; Faiez Zannad
Journal:  Clin Res Cardiol       Date:  2019-05-06       Impact factor: 5.460

5.  Cognitive Function Following Diabetic Ketoacidosis in Children With New-Onset or Previously Diagnosed Type 1 Diabetes.

Authors:  Simona Ghetti; Nathan Kuppermann; Arleta Rewers; Sage R Myers; Jeff E Schunk; Michael J Stoner; Aris Garro; Kimberly S Quayle; Kathleen M Brown; Jennifer L Trainor; Leah Tzimenatos; Andrew D DePiero; Julie K McManemy; Lise E Nigrovic; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; Nicole S Glaser
Journal:  Diabetes Care       Date:  2020-09-22       Impact factor: 19.112

6.  Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis.

Authors:  Nathan Kuppermann; Simona Ghetti; Jeff E Schunk; Michael J Stoner; Arleta Rewers; Julie K McManemy; Sage R Myers; Lise E Nigrovic; Aris Garro; Kathleen M Brown; Kimberly S Quayle; Jennifer L Trainor; Leah Tzimenatos; Jonathan E Bennett; Andrew D DePiero; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; J Michael Dean; Nicole S Glaser
Journal:  N Engl J Med       Date:  2018-06-14       Impact factor: 91.245

7.  Dynamic regulation of plasma matrix metalloproteinases in human diabetic ketoacidosis.

Authors:  Martin Woo; Eric K Patterson; Gediminas Cepinskas; Cheril Clarson; Tatsushi Omatsu; Douglas D Fraser
Journal:  Pediatr Res       Date:  2015-10-22       Impact factor: 3.756

8.  Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis.

Authors:  Xiongfeng Pan; Atipatsa C Kaminga; Shi Wu Wen; Aizhong Liu
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

9.  Human severe sepsis cytokine mixture increases β2-integrin-dependent polymorphonuclear leukocyte adhesion to cerebral microvascular endothelial cells in vitro.

Authors:  Chris Blom; Brittany L Deller; Douglas D Fraser; Eric K Patterson; Claudio M Martin; Bryan Young; Patricia C Liaw; Payam Yazdan-Ashoori; Angelica Ortiz; Brian Webb; Greg Kilmer; David E Carter; Gediminas Cepinskas
Journal:  Crit Care       Date:  2015-04-07       Impact factor: 9.097

10.  Extracellular acidification stimulates GPR68 mediated IL-8 production in human pancreatic β cells.

Authors:  Vikash Chandra; Angeliki Karamitri; Paul Richards; Françoise Cormier; Cyrille Ramond; Ralf Jockers; Mathieu Armanet; Olivier Albagli-Curiel; Raphael Scharfmann
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.